ask="34.47"
ask_size="100"
average_daily_volume="62302"
bid="2.45"
bid_size="100"
book_value="0.53"
change="+0.01"
change_from_200_day_moving_average="-1.11"
change_from_50_day_moving_average="-0.29"
change_from_52_week_high="-3.88"
change_From_52_week_low="0.25"
change_in_percent="+0.39%"
close="2.60"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.64"
ebitda="-16.57M"
eps_estimate_current_year="-3.22"
eps_estimate_next_quarter="-0.80"
eps_estimate_next_year="-2.56"
ex_dividend_date="N/A"
float_shares="5308000"
high="2.71"
high_52_weeks="6.47"
last_trade_date="3/17/2017"
last_trade_price="2.60"
last_trade_size="618"
last_trade_time="4:00pm"
low="2.50"
low_52_weeks="2.35"
market_capitalization="16.37M"
moving_average_200_day="3.71"
moving_average_50_day="2.89"
name="MabVax Therapeutics Holdings
I"
notes="N/A"
one_year_target_price="18.00"
open="2.57"
pe_ratio="N/A"
peg_ratio="-0.01"
percent_change_from_200_day_moving_average="-29.83%"
percent_change_from_50_day_moving_average="-10.01%"
percent_change_from_52_week_high="-59.85%"
percent_change_from_52_week_low="+10.64%"
previous_close="2.59"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.89"
price_per_sales="110.14"
revenue="148054.00"
shares_outstanding="6296000"
short_ratio="2.70"
stock_exchange="NCM"
symbol="MBVX"
volume="48222"
weeks_range_52="2.35 - 6.47"
